NEW YORK, Feb. 21, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Immune Design Corp. (IMDZ) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Merck Sharp & Dohme Corp. (MRK). Stockholders will receive $5.85 for each share of Immune Design Corp. stock that they hold. The transaction is valued at approximately $300 million and is expected to close in the second quarter of 2019.
If you are a stockholder of Immune Design Corp. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/imdz. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at email@example.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.